Live tape
Top 8, mentions 7d14,334NVDA4,850 mentions▲ +0.04GOOGL2,061 mentions▲ +0.04SPY1,736 mentions▲ +0.06QQQ1,554 mentions▲ +0.05AMD1,212 mentions▲ +0.08SPCX1,106 mentions▲ +0.05TSLA954 mentions▲ +0.04SNDK861 mentions▲ +0.05

Equity · Healthcare

TYRA

NASDAQ

Tyra Biosciences (TYRA)

32 USD +1.22% vs prior close
Tyra Biosciences, Inc. price graph

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.

Market cap
1.9B USD
EPS, diluted, year to Dec 2025
−2.01 USD
52-week range
10 USD – 40 USD
Avg volume
197.2K

as of Jul 17, 2026

Have Tyra Biosciences (TYRA) insiders bought or sold shares recently?

In the 90 days to 10 Nov 2026, Tyra Biosciences insiders reported 1 open-market purchase and no sales (SEC Form 4).

Form 4, 90 days to 10 Nov 2026, newest reported trade 9 Sep 2026

1buys
0sells
$20Knet bought
3other filings
Have Tyra Biosciences (TYRA) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
09 Sep 2026Verjee RehanDirectorBuy97220K USD
3 other filings in the window: grants, exercises, tax withholding and transfers, not trades
Have Tyra Biosciences (TYRA) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
15 Sep 2026Harris ToddPresident and CEOAward8648K USD
15 Sep 2026Rueb YuliyaVice President, Finance (PAO)Award2,92527K USD
15 Sep 2026Fuhrman AlanChief Financial OfficerAward9519K USD

Which funds hold Tyra Biosciences (TYRA)?

1 of the 45 institutional funds we track reported a Tyra Biosciences position for the quarter ended 30 Sep 2026 — a combined 564K USD; the latest of those filings landed 06 Nov 2026.

Form 13F

Which funds hold Tyra Biosciences (TYRA)?
FundPositionSharesValueShares q/q
Fisher Asset ManagementTrimmed25,766564K USD−57.2%

What has been filed or recorded for Tyra Biosciences (TYRA)?

The filings we hold for Tyra Biosciences, newest first: 6 quarterly earnings reports, 2 annual reports and 4 reported financial figures, the latest dated 30 Jun 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Tyra Biosciences (TYRA)?
And
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.69 USD
30 Jun 2026FinancialsTotal assets383.4M USDat period end
30 Jun 2026FinancialsTotal equity353.7M USDat period end
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.64 USD
31 Dec 2025Annual reportFY 2025 reportedEPS −2.01 USD
31 Dec 2025FinancialsNet income−119.9M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−2.01 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.50 USD
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.47 USD
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −0.47 USD
31 Dec 2024Annual reportFY 2024 reportedEPS −1.51 USD
30 Sep 2024Quarterly earningsQ3 2024 reportedEPS −0.41 USD

What do people ask about Tyra Biosciences (TYRA)?

From live data
What is Tyra Biosciences’ market cap?1.9B

Tyra Biosciences is worth 1.9B USD by market value as of 17 Jul 2026, which is the share price times the shares on issue from its SEC filings.

Have Tyra Biosciences insiders bought or sold shares recently?1 purchase

In the 90 days to 10 Nov 2026, Tyra Biosciences insiders reported 1 open-market purchase and no sales (SEC Form 4). A further 3 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders

Which funds own Tyra Biosciences?1 of 45

1 of the 45 funds we track reported a Tyra Biosciences position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported position was Fisher Asset Management. See Funds

When did Tyra Biosciences last report earnings?−0.69

Tyra Biosciences last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −0.69 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
  6. SEC EDGARreported earnings figures and scheduled report dates
  7. SEC EDGARValuation computed from SEC EDGAR filings